Sizing clinical trials when comparing bivariate time-to-event outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sizing clinical trials when comparing bivariate time-to-event outcomes

Published:2017-01-24 Issue:9 Volume:36 Page:1363-1382
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Sugimoto Tomoyuki¹,Hamasaki Toshimitsu²^ORCID,Evans Scott R.³,Sozu Takashi⁴

Affiliation:

1. Department of Mathematics and Computer Science; Kagoshima University Graduate School of Science and Technology; Kagoshima Japan

2. Department of Data Science; National Cerebral and Cardiovascular Center; Saita Japan

3. Department of Biostatistics and Center for Biostatistics in AIDS Research; Harvard T.H. Chan School of Public Health; Boston MA U.S.A

4. Department of Information and Computer Technology, Faculty of Engineering; Tokyo University of Science; Tokyo Japan

Funder

JSPS KAKENHI

National Institute Of Allergy Infectious Diseases of the National Institutes of Health

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference29 articles.

1. On semi-competing risks data;Fine;Biometrika,2001

2. Sample size determination for clinical trials with co-primary outcomes: exponential event times;Hamasaki;Pharmaceutical Statistics,2013

3. A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints;Sugimoto;Biostatistics,2013

4. Multiple co-primary endpoints: medical and statistical solutions;Offen;Drug Information Journal,2007

5. Some controversial multiple testing problems in regulatory applications;Hung;Journal of Biopharmaceutical Statistics,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints;Statistics in Medicine;2022-02-23

2. Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints;Pharmaceutical Statistics;2021-08-03

3. Sample Size Determination in Group-Sequential Trials Assessing Interim Futility by Intermediate Composite Endpoints;Statistics in Biopharmaceutical Research;2020-08-24

4. Interim Monitoring for Futility in Clinical Trials With Two Co-Primary Endpoints Using Prediction;Statistics in Biopharmaceutical Research;2019-11-04

5. Adaptive group‐sequential design with population enrichment in phase 3 randomized controlled trials with two binary co‐primary endpoints;Statistics in Medicine;2019-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3